Glassesoff Ltd. is a healthcare technology company specializing in digital vision improvement solutions. The company’s flagship product employs a software-based neurovisual training program designed to enhance near and intermediate vision, aiming to reduce dependence on corrective eyewear for reading and digital device use. By blending principles of neuroscience and vision science, Glassesoff delivers a subscription-based application accessible via smartphone and tablet, enabling users to perform targeted exercises that stimulate neural pathways associated with focusing and visual processing.
Founded in the early 2010s, Glassesoff emerged from academic research conducted at leading ophthalmology and neuroscience laboratories. The company harnessed clinical findings on neuroplasticity to develop its proprietary algorithm, which customizes exercise difficulty based on individual performance. In 2018, Glassesoff completed its initial public offering and began trading on the OTC Markets under the ticker INVS, positioning itself to expand research initiatives and accelerate product development.
Glassesoff serves a global customer base, with distribution networks spanning North America, Europe, and parts of Asia. The company partners with optometrists and vision clinics to integrate its program as a complement to traditional eye care services. Additionally, Glassesoff collaborates with educational institutions and corporate wellness programs to offer vision training solutions that support student learning and employee productivity.
Under the leadership of President and Chief Executive Officer Guy Schwartz, Glassesoff continues to build its presence in the digital health market. The management team includes Chief Technology Officer Dr. Nimrod Carmel, who oversees ongoing research collaborations, and Chief Operating Officer Laura Chen, responsible for strategic partnerships and global expansion. Together, the leadership team is focused on broadening the company’s product offerings and demonstrating long-term clinical benefits through peer-reviewed studies.
AI Generated. May Contain Errors.
